Project Details
Description
The primary objective of this trial is to evaluate the safety and tolerability of multiple intravenous infusions and repeated courses (maximum of two) of ORTHOCLONE OKTcdr4a in patients with active rheumatoid arthritis.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/96 → 9/30/98 |
Funding
- National Center for Research Resources
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.